Company · CIK 1674416
CRISPR Therapeutics AG
| CIK | 1674416 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | V8 |
| Listed | CRSP (Nasdaq) |
| First annual or quarterly report | 2016-11-22 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-281262 | 2024-08-05 | 2025-10-15 | 3 | |
| 333-258274 | 2021-07-29 | 2024-02-13 | 2 | |
| 333-227427 | 2018-09-19 | 2021-01-15 | 10 | |
| 333-221491 | 2017-11-09 | 2018-11-09 | 7 | |
| 333-213577 | 2016-09-09 | 2016-10-19 | 5 |
Filings
28| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-10-15 | 424B5Shelf takedown | 333-281262 | 0001193125-25-240259 |
| 2025-05-19 | 424B5Shelf takedown | 333-281262 | 0000950170-25-074553 |
| 2024-08-05 | S-3ASRShelf registered | 333-281262 | 0000950123-24-007171 |
| 2024-02-13 | 424B5Shelf takedown | 333-258274 | 0001193125-24-032975 |
| 2021-07-29 | S-3ASRShelf registered | 333-258274 | 0001193125-21-229395 |
| 2021-01-15 | 424B5Shelf takedown | 333-227427 | 0001193125-21-010074 |
| 2020-12-11 | 424B5Shelf takedown | 333-227427 | 0001193125-20-315407 |
| 2020-07-01 | 424B5Shelf takedown | 333-227427 | 0001193125-20-185304 |
| 2020-06-29 | 424B5Shelf takedown | 333-227427 | 0001193125-20-182373 |
| 2019-11-21 | 424B5Shelf takedown | 333-227427 | 0001193125-19-297588 |
| 2019-11-19 | 424B5Shelf takedown | 333-227427 | 0001193125-19-295571 |
| 2019-08-30 | 424B5Shelf takedown | 333-227427 | 0001193125-19-235292 |
| 2018-11-09 | 424B5Shelf takedown | 333-221491 | 0001193125-18-322757 |
| 2018-09-24 | 424B5Shelf takedown | 333-221491 | 0001193125-18-281365 |
| 2018-09-21 | 424B5Shelf takedown | 333-227427 | 0001193125-18-279998 |
| 2018-09-19 | 424B5Shelf takedown | 333-227427 | 0001193125-18-277609 |
| 2018-09-19 | S-3ASRShelf registered | 333-227427 | 0001193125-18-277572 |
| 2018-08-31 | 424B5Shelf takedown | 333-221491 | 0001193125-18-265001 |
| 2018-01-05 | 424B5Shelf takedown | 333-221491 | 0001193125-18-004567 |
| 2018-01-03 | 424B5Shelf takedown | 333-221491 | 0001193125-18-000978 |
| 2017-12-04 | EFFECTDeclared effective | 333-221491 | 9999999995-17-003132 |
| 2017-11-09 | S-3Shelf registered | 333-221491 | 0001193125-17-339033 |
| 2016-10-19 | 424B4Final prospectus | 333-213577 | 0001193125-16-741812 |
| 2016-10-18 | EFFECTDeclared effective | 333-213577 | 9999999995-16-005999 |
| 2016-10-14 | S-1/AAmendment | 333-213577 | 0001193125-16-738437 |
| 2016-10-07 | S-1/AAmendment | 333-213577 | 0001193125-16-733213 |
| 2016-09-09 | S-1Registration filed | 333-213577 | 0001193125-16-706569 |
| 2016-05-13 | DRSDraft made public | 377-01325 | 0000950123-16-017103 |